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OBJECTIVES The purpose of this study was to develop a convenient and inexpensive method for identifying
an individual’s risk for hospital readmission for congestive heart failure (CHF) using
information derived exclusively from administrative data sources and available at the time of
an index hospital discharge.
BACKGROUND Rates of readmission are high after hospitalization for CHF. The significant determinants of
rehospitalization are debated.
METHODS Administrative information on all 1995 hospital discharges in New York State which were
assigned International Classification of Diseases–9–Clinical Modification codes indicative of
CHF in the principal diagnosis position were obtained. The following were compared among
hospital survivors who did and did not experience readmission: demographics, comorbid
illness, hospital type and location, processes of care, length of stay and hospital charges.
RESULTS A total of 42,731 black or white patients were identified. The subgroup of 9,112 patients
(21.3%) who were readmitted were distinguished by a greater proportion of blacks, a higher
prevalence of Medicare and Medicaid insurance, more comorbid illnesses and the use of
telemetry monitoring during their index hospitalization. Patients treated at rural hospitals,
those discharged to skilled nursing facilities and those having echocardiograms or cardiac
catheterization were less likely to be readmitted. Using multiple regression methods, a simple
methodology was devised that segregated patients into low, intermediate and high risk for
readmission.
CONCLUSIONS Patient characteristics, hospital features, processes of care and clinical outcomes may be used
to estimate the risk of hospital readmission for CHF. However, some of the variation in
rehospitalization risk remains unexplained and may be the result of discretionary behavior by
physicians and patients. (J Am Coll Cardiol 1999;33:1560–6) © 1999 by the American
College of Cardiology
Congestive heart failure (CHF) is the leading cause of
hospital admission among patients over the age of 65 years
(1). This syndrome is associated with high rates of mortality
and morbidity (2), including hospital readmission (3–6),
thereby posing a significant societal burden (7). Substantial
effort is being devoted to devise safe and effective programs
to reduce preventable hospital admissions and readmissions
for CHF (8–13). Logically, these efforts should focus on
individuals at greatest risk for rehospitalization for CHF, as
CHF is the most common cause for readmission among this
group of patients (3,4,6,8), and this end point is the clinical
outcome most affected by disease state management pro-
grams (9,11). However, the prediction of readmission, like
the prediction of mortality (14), may be imprecise in the
hospital setting. Previous studies of determinants of hospital
admission among patients with CHF have focused on
all-cause readmission rates (3,4), have been limited by small
sample size (4–6) or have been single-center investigations
(4–6). The current study utilized an existing hospital
discharge data set and retrospective analyses to examine the
prediction of rehospitalization for CHF among a large and
diverse group of patients. We sought to determine whether
an individual’s risk for readmission could be calculated at the
time of hospital discharge in a convenient and inexpensive
way using information derived exclusively from administra-
tive data sources.
METHODS
Patients. Information on all 1995 New York State hospital
discharges assigned International Classification of Diseases–
9–Clinical Modification (ICD-9-CM) codes indicative of
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CHF in the principal diagnosis position were obtained from
the Statewide Planning and Research Cooperative System
(SPARCS) database. SPARCS is an agency of the New
York State Department of Health which, by law, incorpo-
rates information or all patients hospitalized in acute care
facilities from various sources including the uniform bill and
uniform discharge abstract submitted by hospitals. Clinical
investigators may petition the Department of Health for
access to some of all of these administrative records. The
application process includes review of the scientific merit of
the proposed project and approval by an institutional review
board or ethics committee. This study was approved by the
institutional review board of the Massachusetts General
Hospital.
The codes used were 428.0, 402.91, 404.93, 428.1,
402.11, 398.91, 404.91, 404.13, 402.01, 404.03, 404.11,
404.01 and 428.9. This method of case selection defined a
group of patients whose primary diagnosis was CHF,
irrespective of procedures performed. The chronologically
first hospital admission during 1995 for each patient was
considered the index admission (or discharge). Patients who
died during their index admission were excluded from this
analysis. To simplify analyses of potentially complex rela-
tionships between ethnicity and other predictors of read-
mission (5,15), patients whose race was reported “un-
known,” “other” or any race other than black or white were
also excluded.
Readmission for CHF was determined by searching the
same data set for subsequent hospitalizations occurring
before December 31, 1995 for each individual who qualified
for inclusion in the study. Readmission was coded as present
or absent for each patient. The records of 3% of the patients
were manually reviewed by trained chart auditors to confirm
the accuracy of the unique patient identifier used to identify
hospital readmission, and to confirm the presence of CHF
based on the documentation of typical symptoms, physical
findings, diagnostic test results and clinical response to
appropriate therapy.
Hospital length of stay was defined as the date of
discharge or death minus the date of admission. Discharges
were classified as “urban” if they occurred at a hospital
located in a county which is part of a Federal Metropolitan
Statistical Area. All other discharges were classified as
“rural.” Discharges were classified as “teaching” if they
occurred at a hospital listed as a primary or affiliated
institution of an accredited internal medicine or family
practice residency program according to the American
Medical Association’s directory of postgraduate medical
training programs (16). All other discharges were classified
as “nonteaching.”
Coexistent illnesses were determined by searching the
principal ICD-9-CM diagnosis code and up to 14 second-
ary diagnosis codes for each patient. Total comorbid disease
was quantified according to the method of Charlson. To
achieve this, a Charlson Comorbidity Index (17), and its
age-modified variant (18), were calculated for each patient.
Process of care was determined by searching the principal
procedure code and up to 14 secondary procedure codes for
each patient. In some cases, similar procedures with closely
related codes were combined to yield clinically relevant
composite rates of technical services. Medical specialty
codes for a maximum of three physicians caring for each
patient were examined. A patient was classified as receiving
care from a cardiologist if any of his or her providers was
listed as a specialist in cardiovascular diseases.
Statistical analyses. Differences between patients readmit-
ted and those not readmitted were analyzed using chi-
square tables (categorical data) and Student unpaired t test
(interval data). To provide the opportunity to both develop
risk scores and test their validity within a single data set, all
patients were randomly assigned to either a derivation
subset or a validation subset. Among patients in the deri-
vation subset only, SAS’s PROC LOGISTIC (19) was used
to determine which of the patient characteristics, hospital
features, processes of care and clinical outcomes had inde-
pendent predictive value for hospital readmission. All pre-
dictors with a significant or borderline statistical relation-
ship with rehospitalization at the univariate level (p # 0.10)
were entered as independent variables in a logistic regression
model for readmission. This technique yielded odds ratios
and confidence intervals for readmission for every predictor
variable tested in the model. After identifying those vari-
ables with significant independent predictive value (p #
0.05 in the logistic regression model), two risk scoring
systems based on these variables were derived. The simple
risk score was computed by adding the number of positive
predictors for readmission present for each patient, then
subtracting the number of negative predictors present. The
modified risk score assigned weights to each positive and
negative predictor based on the odds ratio for that variable
derived from the logistic regression model. The precision of
the single best prediction method developed using data from
the derivation subset only was then tested among patients in
the validation subset only by entering each patient’s risk
score as the independent variable in a logistic regression
model for readmission. In interpreting results, a p value #
0.05 was considered statistically significant. In this report,
results are displayed as mean 6 standard deviation.
RESULTS
Patients and hospitals. A total of 52,010 individual pa-
tients were hospitalized at least once in New York State
Abbreviations and Acronyms
CHF 5 congestive heart failure
ICD-9-CM 5 International Classification of Diseases–
9–Clinical Modification
SPARCS 5 Statewide Planning and Research
Cooperative System
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during 1995 with the chosen ICD-9-CM codes. Of these,
6,116 were excluded because race was reported as neither
black nor white (Native American, 102 patients; Asian, 518;
other race, 3,330; unknown race, 2,196). Of the remaining
45,894 patients, 3,163 died during their index hospitaliza-
tion and were also excluded from this analysis. Thus, the
study sample comprised 42,731 black or white patients. Of
these, 9,112 (21.3%) were rehospitalized at least once for
CHF after their index discharge; 33,619 (78.7%) were not.
In the opinion of the chart auditors, CHF was present and
was a primary reason for hospitalization in 96% of the 1,220
cases reviewed manually.
A total of 236 of New York’s 243 acute care hospitals
contributed at least one patient to the study sample of
42,731. Among these 236 institutions, the caseload per
hospital ranged from 1 to 590 patients, with a median of
274. Of all discharges, 10.2% occurred at rural hospitals;
51.9% of them occurred at teaching institutions.
Among the 42,731 patients included in this study, mean
age was 73.7 6 13.2 years. Women comprised the majority
of the cohort (56.4%). Blacks formed 18.2% of the group.
The mean Charlson Comorbidity Index was 2.5 6 1.6, and
mean age-modified Charlson Comorbidity Index was 5.5 6
2.0. Mean length of stay during the index admission was
9.2 6 13.5 days, and mean hospital charges were $11,026 6
14,748. The median postdischarge “follow-up” period for all
patients was 6.9 months. Because patients in the rehospi-
talized group tended to experience their index discharge
somewhat earlier during calendar year 1995, their median
period of follow-up was 8.5 months. The same time period
was 6.4 months for the nonrehospitalized group. Among
patients who had one or more rehospitalizations, the me-
dian time from their index discharge to their first readmis-
sion was 91 days. Mortality rate during the index admission
among black or white patients was 6.9%; the rate of death
during subsequent hospitalizations was 7.9% (p , 0.0001).
Clinical characteristics. Table 1 displays the basic demo-
graphic characteristics, comorbid illnesses and comorbidity
scores of the entire cohort, stratified by readmission status.
Clinically relevant features distinguishing the rehospitalized
group included a higher proportion of blacks, a higher
prevalence of Medicare and Medicaid insurance, a lower
prevalence of health maintenance organization and indem-
nity insurance and a higher prevalence of ischemic heart
disease, idiopathic cardiomyopathy, prior cardiac surgery,
peripheral vascular disease, renal disease, diabetes mellitus
and anemia. The rehospitalized group also had higher mean
comorbidity scores.
Process of care. Processes of care during the index hospital
admission are shown in Table 2, stratified by readmission
status. Patients who were readmitted were less likely to
undergo the following procedures during their index hospi-
talization: echocardiography, exercise stress testing, cardiac
catheterization, coronary revascularization or any cardiac
surgical procedure. Readmitted patients were somewhat
more likely to have telemetry electrocardiographic monitor-
ing during their index hospitalization.
Resource utilization and crude clinical outcomes. Table
3 displays the resource utilization and crude clinical out-
comes during the index hospital admission, stratified by
readmission status. Patients rehospitalized were less likely to
be discharged to nursing homes, and more likely to receive
Table 1. Demographic Features and Comorbid Illnesses of
42,731 Patients Readmitted or Not Readmitted for Congestive
Heart Failure*
Clinical Feature
Not Readmitted
(n 5 33,619)
Readmitted
(n 5 9,112)
Age (yr)† 73.8 6 13.4 73.3 6 12.8
Female gender 55.6 55.8
Black race† 17.5 20.9
Medical insurance
Medicare insurance† 73.1 75.3
Medicaid insurance† 8.4 10.7
HMO insurance† 3.1 2.4
Indemnity insurance† 10.2 7.9
Hospital location and type
Rural, teaching 1.5 1.5
Rural, nonteaching 8.7 8.7
Urban, teaching 50.1 51.6
Urban, nonteaching 39.7 38.2
Any rural hospital 10.2 10.2
Any teaching hospital 51.6 53.1
Transferred from acute care
facility
1.4 1.2
Comorbid illness
Hypertensive heart disease 44.9 45.0
Myocardial infarction 2.7 2.9
Ischemic heart disease† 48.4 53.0
Other cardiomyopathies† 12.0 15.8
Valvular heart disease 20.1 21.2
Prior cardiac surgery† 10.0 12.3
Shock 0.3 0.2
Atrial fibrillation or flutter 27.4 26.7
Life-threatening arrhythmia
disorder
3.5 3.9
Cerebrovascular disease 5.2 4.6
Peripheral vascular disease† 8.4 9.6
Acute or chronic renal
disease†
18.5 24.4
Chronic lung disease 28.1 28.9
Acute pneumonia 6.0 5.3
Diabetes mellitus† 30.9 38.8
Anemia† 16.2 18.2
Active or inactive cancer 6.5 5.8
Drug or alcohol abuse 2.4 2.7
Comorbidity scores
Charleson Index† 2.5 6 1.6 2.7 6 1.7
Age-modified Charlson
Index†
5.4 6 2.0 5.6 6 2.0
*Continuous variables are reported as mean 6 standard deviation; categorical variables
are reported as percentage of the group. †p # 0.05 for comparison between groups.
HMO 5 health maintenance organization.
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home health care services, after their index discharge.
Length of stay and hospital charges during the index
admission were not different between groups.
Multivariable analyses. The logistic regression model for
rehospitalization, with a c statistic of 0.62, retained 12
predictors of higher risk of readmission and four predictors
of lower risk of readmission. The predictors of higher risk
were black race (odds ratio 5 1.28, 95% confidence inter-
val 5 1.16 to 1.41), Medicare insurance (1.66, 1.38 to 2.00),
Medicaid insurance (1.92, 1.57 to 2.36), home health care
services after discharge (1.10, 1.01 to 1.21), ischemic heart
disease (1.25, 1.16 to 1.34), valvular heart disease (1.19, 1.09
to 1.29), diabetes mellitus (1.45, 1.33 to 1.58), renal disease
(1.35, 1.23 to 1.49), chronic lung disease (1.10, 1.02 to
1.20), idiopathic cardiomyopathy (1.46, 1.32 to 1.61), prior
cardiac surgery (1.16, 1.04 to 1.29) and use of telemetry
monitoring during index hospitalization (1.13, 1.01 to
1.27). The predictors of lower risk were treatment in a rural
hospital (0.87, 0.78 to 0.98), discharge to a skilled nursing
facility (0.68, 0.59 to 0.79), performance of echocardiogra-
phy during the index admission (0.78, 0.73 to 0.85) and
performance of cardiac catheterization during the index
admission (0.60, 0.49 to 0.73).
Composite risk scores. In the simple scoring system (Ta-
ble 4), one integer was added for each predictor of higher
Table 2. Processes of Care During the Index Hospital
Admission for 42,731 Patients Readmitted or Not Readmitted
for Congestive Heart Failure*
Processes of Care
Not Readmitted
(n 5 33,619)
Readmitted
(n 5 9,112)
Specialty services
Cardiology 20.2 21.2
Physical or occupational
therapy
1.8 1.8
Noninvasive cardiac services
Echocardiography† 30.3 26.1
Nuclear ventriculogram 6.0 5.5
Telemetry monitoring† 9.7 10.7
Holter monitoring 1.8 1.5
Exercise stress testing† 2.4 1.5
Critical care
Pulmonary artery
catheterization
1.2 1.5
Any central vascular
catheterization
1.6 2.0
Mechanical ventilatory
support
4.4 4.5
Renal dialysis 3.4 2.8
Infusion of inotropic drug 6.6 7.2
Invasive cardiac services
Cardiac catheterization† 4.6 2.8
Any coronary revascularization
procedure†
0.4 0.1
Heart transplantation 0.1 0.0
Any cardiac surgery† 0.5 0.2
Electrophysiology testing 0.3 0.2
Permanent pacemaker
implantation
1.2 1.0
*Categorical variables are reported as percentage of the group. †p # 0.05 for
comparison between groups.
Table 3. Resource Utilization and Crude Clinical Outcomes
During the Index Hospital Admission for 42,731 Patients
Readmitted or Not Readmitted for Congestive Heart Failure*
Not
Readmitted
(n 5 33,619)
Readmitted
(n 5 9,112)
Total length of stay
(days)
9.2 6 14.3 9.1 6 10.2
Total hospital charges
(dollars)
11,062 6 15,175 10,895 6 13,056
Any intensive care unit
care
30.1 30.6
Procedural complication 1.1 0.8
Transfer to skilled
nursing facility†
8.2 5.6
Transfer to acute care
hospital
4.0 4.3
Home services after
discharge†
15.6 18.0
Discharge against medical
advice†
1.5 1.8
*Continuous variables are reported as mean 6 standard deviation; categorical variables
are reported as percentage of the group. †p # 0.05 for comparison between groups.
Table 4. Calculation of Simple Risk Score for Readmission
Points
Baseline value 4
For each of the following present: Add 1 point
Black race
Medicare insurance*
Medicaid insurance*
Home health care services after discharge
Ischemic heart disease
Valvular heart disease
Diabetes mellitus
Renal disease
Chronic lung disease
Idiopathic cardiomyopathy
Prior cardiac surgery
Use of telemetry during index
hospitalization
For each of the following present: Subtract 1 point
Treatment at a rural hospital
Discharge to a skilled nursing facility
Echocardiogram performed during index
hospitalization
Cardiac catheterization performed during
index hospitalization
Range of possible scores 0 to 15
*Indicates primary insurance, therefore a patient may be given only one point for
either Medicare or Medicaid insurance.
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risk present, and one subtracted for each predictor of lower
risk present. To avoid negative values, a correction factor of
14 was added to this sum. Thus, the range of potential
values for the simple risk score was 0 to 15. (Because a
patient’s primary insurance could not have been both
Medicare and Medicaid, a maximum of 11 positive predic-
tors could be present for any individual. A single variable
“Medicare or Medicaid” was not created because of the
different odds ratios associated with these two predictors.)
Among patients in the derivation subset only, a logistic
regression model for readmission with each patient’s simple
risk score as the independent variable had a c statistic of
0.60, indicating that the risk score was moderately but
significantly predictive of readmission (p , 0.001). The
predictive value of this simple risk score was not reduced by
grouping all patients with a score of 0 to 3 into a single unit
and all patients with a score $11 into another single unit (c
statistic of 0.60, p , 0.001). The modified scoring system
based on weighting the 16 predictor variables proportional
to their odds ratios performed no better than the simple
system (c statistic of 0.61, p , 0.001).
Validation of risk scores. Among patients in the validation
subset only, a logistic regression model for readmission with
each patient’s simple risk score as the independent variable
had a c statistic of 0.60, indicating that the risk score was
moderately but significantly predictive of readmission (p ,
0.001). Thus, this model performed equally as well in the
validation subset as it did in the derivation subset. The
actual readmission rates observed among patients in the
validation subset as a function of incrementally higher
simple risk scores is shown in Figure 1. As shown, the
observed readmission rates ranged from 9.8% among pa-
tients with simple risk scores from 0 to 3 to 45.4% among
patients with scores $11.
DISCUSSION
In this study, we examined how patient characteristics,
hospital features, process of care and clinical outcomes, as
derived from an administrative data set, relate to the risk for
readmission among a large and diverse group of patients
treated for CHF. The principal findings of this study are: 1)
21.3% of the 42,731 black or white hospital survivors
admitted for CHF in New York State during 1995 were
readmitted with the same diagnosis during a median
follow-up period of 6.9 months after their first discharge
that year; 2) using univariate statistical techniques, we found
black race, Medicare and Medicaid insurance, ischemic
heart disease, idiopathic cardiomyopathy, prior cardiac sur-
gery, peripheral vascular disease, renal disease, diabetes
mellitus and anemia to be related to a greater risk of
readmission; 3) using univariate statistical techniques, we
found that patients undergoing echocardiography, exercise
stress testing, cardiac catheterization, coronary revascular-
ization or any cardiac surgical procedure were less likely to
be readmitted; 4) a simple and convenient scoring system
based on administrative data, which can be calculated at the
time of a patient’s index hospital discharge, may be used to
estimate his or her risk of readmission, and 5) there is
residual variation in hospital readmission not explained by
the regression models developed in this study.
Previous studies. In analyzing a large administrative data
set, Krumholz et al. found male gender, prior hospitaliza-
tion, higher comorbidity score, treatment in a tertiary care
hospital and prolonged length of stay during the index
hospitalization to be important predictors of all-cause read-
mission among Medicare patients hospitalized in Connect-
icut (3). These investigators could not study the effect of
invasive cardiac procedures because of their choice of
Diagnosis-Related Group inclusion criteria. In examining
outcomes among a small number of patients treated at a
single urban university teaching center, Vinson et al. found
that past hospitalizations, prior CHF, acute myocardial
ischemia and uncontrolled hypertension were significant
predictors of all-cause readmission (4). In both studies (3,4),
age was not an important predictor. In examining CHF
admissions among a small number of black patients treated
at a single urban university teaching hospital, Ghali et al.
found that hospitalization for decompensated CHF could
be explained in most cases by poor patient compliance,
cardiac arrhythmias, emotional and environmental factors,
poor medical care, pulmonary infection or thyrotoxicosis
(5). Unfortunately, Ghali et al. did not include a comparison
group of nonhospitalized patients to allow for determina-
tion of the significant predictors of admission or readmis-
sion. Chin and Goldman, examining a small number of
patients treated at a single urban university teaching hospi-
Figure 1. Rates of hospital readmission for congestive heart failure
(CHF) observed among 21,504 patients in the validation subset
based on their simple risk score.
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tal, found that single marital status, hypotension, absent
electrocardiographic repolarization abnormalities and
higher Charlson Comorbidity Index were significant mul-
tivariable correlates of the combined end point of postdis-
charge death or hospital readmission (6). These authors did
not report the determinants of readmission as an isolated
end point.
From a methodologic viewpoint, our study differed from
the others by including a much larger number of patients,
perhaps with more diffuse demographic characteristics.
Processes of care during the index hospitalization were
examined as potential predictors based on their putative
relationship with clinical events (20). Conversely, our data
set lacked some of the richness of clinical information
available to Vinson and colleagues (4), Ghali et al. (5) and
Chin and Goldman (6). The results of our study were
concordant with the prior investigations in describing co-
morbid illness as a major determinant of hospitalization
risk. We, too, found that age was not a significant predictor
of hospitalization after adjustment for other factors. Like
Krumholz et al. (3), we found that patients treated at urban
hospitals were more likely to be readmitted. In contrast, we
found no relationship between readmission risk and gender
or prior length of stay. The limitations of our data set
precluded the opportunity to study prior hospitalization,
social support and compliance as predictors of rehospital-
ization. Our study provided the additional insight that, after
adjustment for other factors, race, medical insurance type
and certain processes of care are significant positive or
negative predictors of the risk for readmission for CHF.
Moreover, our study yielded a framework for combining
these multiple risk states to formulate a composite CHF
readmission risk score—a utility not provided by previous
authors.
Unexplained variation in readmission. Our results indi-
cate that a prediction rule derived from administrative data
collected during a patient’s index hospitalization only par-
tially explains the risk for readmission. Our simple risk
scoring system is convenient and inexpensive, as it is based
on data that are readily available and not dependent upon
case-by-case chart review (21). More precise mathematical
prediction of readmission risk that reduces the unexplained
residual variation in this end point would require additional
data input from two broad domains: 1) patient- and
disease-specific characteristics identifiable during the index
hospitalization; and 2) factors related to the patient’s CHF
and other medical conditions and their management as-
sessed after discharge.
Regarding the first of these two domains, the limitations
of administrative data are well known (21–23). Illness
severity is not fully captured in such sources of data, due to
inadequate clinical information such as disease-specific
functional status, physical examination findings, laboratory
results, medication use, social support structure or valid
global measures of risk. Thus, incorporation of more de-
tailed measures of CHF severity and treatment, and global
health status, might have improved the accuracy of predict-
ing readmission. For example, information regarding prior
hospitalizations (3,4), angiotensin-converting enzyme in-
hibitor use (24), digitalis use (25), emotional support (26)
and quality of care (27) would likely be of value. Unfortu-
nately, with the limitations of existing information systems,
costly chart review would most often be required to collect
and quantify these putative predictors. Such a process would
not be feasible for studying large groups of patients or
hospitals (3,21).
Regarding the postdischarge domain, many factors may
impact on the risk for readmission. For example, the timing
and frequency of medical follow-up (28), medication use
(24,25), compliance with medical recommendations (5),
participation in a care management program (9–13) and the
specialty of the treating physician (29,30) affect the likeli-
hood of hospitalization for CHF. Physician discretionary
behavior also affects hospital stays for CHF (31). Other
factors that are difficult to measure and quantify, such as a
patient’s sense of security or well-being, likely contribute to
the variation in rehospitalization. Thus, were it feasible and
affordable to measure and quantify these factors, the math-
ematical prediction of readmission risk would probably
become more precise. Of course, those measurements that
could only be made after discharge would not be of utility in
quantifying risk before a patient leaves the hospital.
Implications. The potential implications of our study de-
serve comment. From the clinical viewpoint, quantification
of readmission risk at the time of hospital discharge is of
value in that it provides the opportunity to enroll high risk
patients into proactive care management programs. Pro-
grams of this type (9–13) have been demonstrated to be
effective in reducing costs from hospitalization for CHF
while improving quality of care and patient functional
status. The use of the scoring system developed in the
current study brings some refinement to the prediction of
readmission risk, as it differentiates those with very low risk
from those at intermediate and high risk—a much more
precise process than assuming that all previously hospital-
ized patients have equally high risk (9). From the health
services research viewpoint, our findings may be of use in
comparing risk-stratified readmission rates among groups of
patients, such as those treated within differing health care
delivery systems (28,32).
Study limitations. As the present study was based on
administrative discharge data, we cannot be sure how our
patient groups truly related to one another upon entry into
the hospital in terms of CHF severity or global health
status. Furthermore, because the statistical methods em-
ployed in this study are designed only to examine associa-
tions between variables, we cannot draw conclusions about
how or why predictor variables (such as hospital type or
process of care) caused or prevented readmission. We
cannot discount the possibility that biases in hospitals’
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coding practices affected the results of this study. Patients
living in areas near the geographic borders of New York, or
moving from the state after their index discharge, may have
been rehospitalized in hospitals outside of the state, thus
rendering our study potentially vulnerable to slight under-
estimation of the rate of readmission, but not necessarily
weakening the prediction of this event. As hospital read-
missions for CHF were the only data available during the
postdischarge period, cumulative mortality rates would by
necessity be underestimates and are therefore not reported.
As our study sample was limited to black or white patients
treated in a single state during a single year, our results may
not be generalizable to all patients hospitalized for CHF.
Because our study, by design, derived prediction rules
exclusively from administrative data, we were forced to
exclude potentially important clinical predictors such as a
history of prior hospitalizations (3) and psychosocial and
behavioral factors (5,26). In point of fact, it is likely that the
most powerful prediction methods are derived from a
combination of administrative data and a few select clinical
variables that are obtained by chart review (33).
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